Health Science
New products can capture the anti-SARS-CoV-2 antibody or ACE2 protein from cell or serum sample
| 2 min read
In lab experiments, both the lung cell and immune cell types of nanosponges caused the SARS-CoV-2 virus to lose nearly 90 percent of its "viral infectivity"
| 5+ min read
First deployment at the Wisma Atria shopping mall in Singapore set for July 15, 2020
| 2 min read
Gravity affects protein assembly related to Alzheimer's disease
| 1 min read
Analysis of data from 16 groups of COVID-19 patients suggest 'silent' carriers may exacerbate efforts to stop spread of the disease
| 2 min read
Labs to be used on corporate, manufacturing, higher ed campuses
| 4 min read
Authors of a recent Nature Medicine commentary propose six broad actions that governments should take to improve their responses to COVID-19 and future health crises
| 2 min read
Research involving blood vessels, type, and proteins may help us determine who is most likely to get sick and how severe their illness will be
| 3 min read
Salk and Yale study of influenza could inform vaccines for COVID-19 and other lung diseases
| 3 min read
A time of crisis such as this offers an opportunity for lab leaders to re-evaluate their safety program, and identify areas of improvement
| 1 min read
Evidence is mounting that SARS-CoV-2 uses heparan sulfates during the initial attachment to hosts cells, and this interaction appears to increase the affinity for the critical receptor, ACE
| 2 min read
How the ZetaView Nanoparticle Tracking Analyzer is helping researchers develop a new approach for vaccine delivery based on engineering the natural ability of resident gut bacteria
| 2 min read
